found that after MSC-IL15 treatment, the recovered mice were resistant to pancreatic tumor re-attack, suggesting that MSC-IL15 induced a tumor-specific T cell immune memory response, thereby eradicating established pancreatic tumors in mice (120). The gene discussed is IL15; the disease is pancreatic neoplasm.